menu
    • menu
    [{"orgOrder":0,"company":"NeuroVive Pharmaceutical AB","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Undisclosed","country":"SWEDEN","productType":"Peptide, Unconjugated","year":"2012","type":"Inapplicable","leadProduct":"Cyclosporine","moa":"Cyclophilin A","graph1":"Undisclosed","graph2":"Phase I","graph3":"NeuroVive Pharmaceutical AB","amount2":0,"highestDevelopmentShortName":"Ph I","therapeuticAreaShortName":"","amount2New":0,"dosageForm":"Injection","sponsorNew":"NeuroVive Pharmaceutical AB \/ Undisclosed","highestDevelopmentStatusID":"6","companyTruncated":"NeuroVive Pharmaceutical AB \/ Undisclosed"},{"orgOrder":0,"company":"NeuroVive Pharmaceutical AB","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Trauma (Emergency, Injury, Surgery)","country":"SWEDEN","productType":"Peptide, Unconjugated","year":"2013","type":"Inapplicable","leadProduct":"Cyclosporine","moa":"Cyclophilin A","graph1":"Trauma (Emergency, Injury, Surgery)","graph2":"Phase II","graph3":"NeuroVive Pharmaceutical AB","amount2":0,"highestDevelopmentShortName":"Ph II","therapeuticAreaShortName":"Trauma","amount2New":0,"dosageForm":"Infusion","sponsorNew":"NeuroVive Pharmaceutical AB \/ Undisclosed","highestDevelopmentStatusID":"8","companyTruncated":"NeuroVive Pharmaceutical AB \/ Undisclosed"},{"orgOrder":0,"company":"NeuroVive Pharmaceutical AB","sponsor":"Region Skane","pharmaFlowCategory":"DU","therapeuticArea":"Nephrology","country":"SWEDEN","productType":"Peptide, Unconjugated","year":"2015","type":"Inapplicable","leadProduct":"Cyclosporine","moa":"Cyclophilin A","graph1":"Nephrology","graph2":"Phase II","graph3":"NeuroVive Pharmaceutical AB","amount2":0,"highestDevelopmentShortName":"Ph II","therapeuticAreaShortName":"Nephrology","amount2New":0,"dosageForm":"Injection","sponsorNew":"NeuroVive Pharmaceutical AB \/ Region Skane","highestDevelopmentStatusID":"8","companyTruncated":"NeuroVive Pharmaceutical AB \/ Region Skane"}]

    Find Clinical Drug Pipeline Developments & Deals by NeuroVive Pharmaceutical AB

    Menu

    NeuroVive Pharmaceutical AB

    EVENTS

    • Webinars & Exhibitions

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass
    Xls
    Filters Filter
    ×
    FILTER:
    filter
    Company Name
      filter

      Year

        filter

        DEALS // DEV.

          filter

          Country

            filter
            Sponsor
              filter

              Therapeutic Area

                filter

                Study Phase

                  filter

                  Deal Type

                    filter

                    Product Type

                      filter

                      Dosage Form

                        filter

                        Lead Product

                          filter

                          Target

                            Loading...
                            refresh Filters
                            refresh Reset Filter
                            refresh Reset Filter
                            price-trend All Developments

                            Therapeutic Area by Lead Product

                            Study Phase by Lead Product

                            Company by Lead Product

                            Top Deals by Deal Size (USD bn)

                            01

                            NeuroVive Pharmaceutical AB

                            Sweden arrow
                            AAPS
                            Not Confirmed

                            NeuroVive Pharmaceutical AB

                            Sweden arrow
                            AAPS
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Cyclosporine

                            Therapeutic Area : Nephrology

                            Study Phase : Phase II

                            Sponsor : Region Skane

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Ciclosporin to Protect Renal Function In Cardiac Surgery

                            Details : Ciclosporin is a Protein drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of Acute Kidney Injury.

                            Product Name : Undisclosed

                            Product Type : Peptide, Unconjugated

                            Upfront Cash : Inapplicable

                            March 24, 2015

                            Lead Product(s) : Cyclosporine

                            Therapeutic Area : Nephrology

                            Highest Development Status : Phase II

                            Sponsor : Region Skane

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            02

                            NeuroVive Pharmaceutical AB

                            Sweden arrow
                            AAPS
                            Not Confirmed

                            NeuroVive Pharmaceutical AB

                            Sweden arrow
                            AAPS
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Cyclosporine

                            Therapeutic Area : Trauma (Emergency, Injury, Surgery)

                            Study Phase : Phase II

                            Sponsor : Undisclosed

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Copenhagen Head Injury Ciclosporin (CHIC) Study

                            Details : Cyclosporine A is a Protein drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of Brain Injuries, Traumatic.

                            Product Name : Undisclosed

                            Product Type : Peptide, Unconjugated

                            Upfront Cash : Inapplicable

                            April 05, 2013

                            Lead Product(s) : Cyclosporine

                            Therapeutic Area : Trauma (Emergency, Injury, Surgery)

                            Highest Development Status : Phase II

                            Sponsor : Undisclosed

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            03

                            NeuroVive Pharmaceutical AB

                            Sweden arrow
                            AAPS
                            Not Confirmed

                            NeuroVive Pharmaceutical AB

                            Sweden arrow
                            AAPS
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Cyclosporine

                            Therapeutic Area : Undisclosed

                            Study Phase : Phase I

                            Sponsor : Undisclosed

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            A Study to Compare the Bioavailability and Pharmacokinetics of Cyclosporine After Intravenous Administration o...

                            Details : Sandimmune is a Protein drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of undefined medical condition.

                            Product Name : Undisclosed

                            Product Type : Peptide, Unconjugated

                            Upfront Cash : Inapplicable

                            September 25, 2012

                            Lead Product(s) : Cyclosporine

                            Therapeutic Area : Undisclosed

                            Highest Development Status : Phase I

                            Sponsor : Undisclosed

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth